论文部分内容阅读
目的了解我院口服心血管药物的使用情况及变化趋势,为指导临床合理用药提供参考。方法采用WHO药物统计中心设定的限定日剂量(DDD)法及金额排序法对我院2005—2007年口服心血管药物的使用情况进行评估。结果2005—2007年,我院口服心血管药物DDDs增长了38.41%。用药金额却出现了负增长(-5.12%);用药频数排前5的分别是硝苯地平及缓释片,硝酸异山梨酯片,依那普利片、阿斯匹林肠溶片、地高辛片等;序号比≥1的品种占多数。用药金额较大的药物有美托洛尔缓释片,洛伐他汀胶囊,银杏叶片等(序号比<0.5)。结论总体药物的使用基本合理。应针对心血管药物种类偏少的现状,提出建议,有针对性地增加心血管药物品种,满足医患用药需要。
Objective To understand the use of oral cardiovascular drugs and trends in our hospital, to provide guidance for clinical rational drug use. Methods The use of the DDD method and the amount ranking method set by the WHO Center for Drug Statistics to evaluate the use of oral cardiovascular drugs in our hospital from 2005 to 2007 were evaluated. Results 2005-2007, our hospital oral administration of cardiovascular drugs DDDs increased by 38.41%. The amount of medication but there was a negative growth (-5.12%); medication frequency of the top 5 are nifedipine and sustained-release tablets, isosorbide dinitrate tablets, enalapril tablets, aspirin enteric-coated tablets, Xin tablets, etc .; serial number ≥ 1 varieties accounted for the majority. Drugs with a larger amount of drugs metoprolol sustained release tablets, lovastatin capsules, ginkgo leaves (serial number <0.5). Conclusion The overall use of drugs is reasonable. Should focus on the current situation of cardiovascular drugs less, make recommendations, targeted to increase the variety of cardiovascular drugs to meet the needs of medical patients.